Prognostic Impact of Lymphoid Enhancer Factor 1 Expression and Serum Galectin.3 in Egyptian AML Patients

Background. Deregulation of the Wnt signaling pathway had a role in haematological malignancies. Previous studies reported that lymphoid enhancer factor 1 (LEF1) expression and serum Galectin-3 level could affect clinical parameters and outcome in acute myeloid leukemia patients, but as far as we kn...

Full description

Bibliographic Details
Main Authors: M. A. ElBaiomy, S. Aref, M. El Zaafarany, Sara Atwa, Tamer Akl, Wafaa El-Beshbishi, Shaimaa El-Ashwah, L. Ibrahim, M. El-Ghonemy
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Advances in Hematology
Online Access:http://dx.doi.org/10.1155/2019/2352919